| 1. | Bongso A, Fong CY.The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.Stem Cell Rev, 2013, 9(2):226-240. | 
				                                                        
				                                                            
				                                                                | 2. | Zebardast N, Lickorish D, Davies JE.Human umbilical cord perivascular cells (HUCPVC):A mesenchymal cell source for dermal wound healing.Organogenesis, 2010, 6(4):197-203. | 
				                                                        
				                                                            
				                                                                | 3. | Hong SH, Maghen L, Kenigsbcerg S, et al.Ontogeny of human umbilical cord perivascular cells:molecular and fate potential changes during gestation.Stem Cells Dev, 2013, 22(17):2425-2439. | 
				                                                        
				                                                            
				                                                                | 4. | Librach CL, Yie SM, Xiao R.Smmethod of isolation and use of cells derived from first trimester umbilical cord tissue.US, 20090074731[P].2009-03-19. | 
				                                                        
				                                                            
				                                                                | 5. | Lumelsky N, Blondel O, Laeng P, et al.Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.Science, 2001, 292(5520):1389-1394. | 
				                                                        
				                                                            
				                                                                | 6. | Jiang W, Shi Y, Zhao D, et al.In vitro derivation of functional insulin-producing cells from human embryonic stem cells.Cell Res, 2007, 17(4):333-344. | 
				                                                        
				                                                            
				                                                                | 7. | Lee SH, Song KS, Kim JY, et al.Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.Bioorg Med Chem, 2011, 19(19):5813-5832. | 
				                                                        
				                                                            
				                                                                | 8. | Otake K, Azukizawa S, Takahashi K, et al.2-Acyl-tetrahydroisoquinoline-3-carboxylic acids:lead compounds with triple actions, peroxisome proliferator-activated receptor α/γ agonist and protein-tyrosine phosphatase 1B inhibitory activities.Chem Pharm Bull (Tokyo), 2011, 59(7):876-879. | 
				                                                        
				                                                            
				                                                                | 9. | Shapiro AM, Lakey JR, Ryan EA, et al.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med, 2000, 343(4):230-238. | 
				                                                        
				                                                            
				                                                                | 10. | Matsumoto S, Tanaka K.Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs).J Hepatobiliary Pancreat Surg, 2005, 12(3):227-230. | 
				                                                        
				                                                            
				                                                                | 11. | Suva D, Garavaglia G, Menetrey J, et al.Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells.J Cell Physiol, 2004, 198(1):110-118. | 
				                                                        
				                                                            
				                                                                | 12. | Yu M, Xiao Z, Shen L, et al.Mid-trimester fetal blood-derived adherent cells share characteristics similar to mesenchymal stem cells but full-term umbilical cord blood does not.Br J Haematol, 2004, 124(5):666-675. | 
				                                                        
				                                                            
				                                                                | 13. | Tsai MS, Lee JL, Chang YJ, et al.Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.Hum Reprod, 2004, 19(6):1450-1456. | 
				                                                        
				                                                            
				                                                                | 14. | Guillot PV, Gotherstrom C, Chan J, et al.Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.Stem Cells, 2007, 25(3):646-654. | 
				                                                        
				                                                            
				                                                                | 15. | Sarugaser R, Lickorish D, Baksh D, et al.Human umbilical cord perivascular (HUCPV) cells:a source of mesenchymal progenitors.Stem Cells, 2005, 23(2):220-229. | 
				                                                        
				                                                            
				                                                                | 16. | Can A, Karahuseyinoglu S.Concise review:human umbilical cord stroma with regard to the source of fetus-derived stem cells.Stem Cells, 2007, 25(11):2886-2895. |